# FDA recall D-132-2013

> **West-ward Pharmaceutical Corp.** · Class II · drug recall initiated 2012-11-30.

## Product

Lisinopril and Hydrochlorothiazide Tablets, 20 mg/25 mg, packaged in a) 100-count tablets per bottle (NDC 0143-1264-01) and b) 1000-count tablets per bottle (NDC 0143-1264-10), Rx only, Manufactured by: West-ward Pharmaceutical Corp., Eatontown, NJ 07724.

## Reason for recall

Presence of Foreign Substance: Reports of gray smudges identified as minute stainless steel particulates were found in the recalled tablets.

## Distribution

Nationwide and Puerto Rico

## Key facts

- **Recall number:** D-132-2013
- **Recalling firm:** West-ward Pharmaceutical Corp.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2012-11-30
- **Report date:** 2013-01-30
- **Termination date:** 2014-07-09

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Eatontown, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-132-2013

## Citation

> AI Analytics. FDA recall D-132-2013. Retrieved 2026-06-02 from https://api.ai-analytics.org/recall/D-132-2013. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*